Oncolytic viruses have also been modified to encode IL-12, alone or along with other molecules (GM-CSF or IL-15), in order to promote and enhance both CD8 T and NK cell-mediated anti-tumor responses [147,192,206,207,208,209]. This evidence concerns the gene CD8A and neoplasm.